ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,042Medicare Part D Prescriptions Filled, Including Refills

Rank: 222 out of 944

$460K Total Retail Price of All Prescriptions

Rank: 252 out of 944

421 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Wisconsin
Lower avg

Schedule Two
Controlled Substances

18% of this provider’s 421 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

24% of this provider’s 421 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 4,379 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Wisconsin
AMLODIPINE BESYLATE 516 289 1 5
SIMVASTATIN 393 239 2 1
OMEPRAZOLE 285 146 3 4
LISINOPRIL 279 133 4 3
FUROSEMIDE 234 180 5 6
HYDROCODONE-ACETAMINOPHEN 210 70 S3 6 10
ALLOPURINOL 156 94 7 22
TRAMADOL HCL 147 46 8 21
LOSARTAN POTASSIUM 145 49 9 16
OXYCODONE-ACETAMINOPHEN 137 74 S2 10 62
HYDROCHLOROTHIAZIDE 134 62 11 9
ACETAMINOPHEN-CODEINE 133 70 S3 12 95
METFORMIN HCL 132 52 13 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 129 51 14 29
PROAIR HFA 127 40 15 56
WARFARIN SODIUM 126 81 16 7
OXYCODONE HCL-ACETAMINOPHEN 120 33 S2 17 127
CARVEDILOL 119 78 18 30
TRIAMTERENE-HCTZ 108 59 19 33
POTASSIUM CHLORIDE 108 78 19 15
ALENDRONATE SODIUM 104 71 21 20
ATORVASTATIN CALCIUM 101 30 22 13
DIOVAN 100 50 23 38
NAPROXEN 94 36 24 113
CLOPIDOGREL 91 42 25 36
ZOLPIDEM TARTRATE 83 28 26 25
IBUPROFEN 83 18 26 140
NEXIUM 79 26 28 53
OXYCODONE HCL 79 34 S2 28 50
METOPROLOL TARTRATE 79 41 28 8
GLIPIZIDE 75 60 31 51
CRESTOR 75 31 31 28
DICLOFENAC SODIUM 73 52 33 106
CLONIDINE HCL 69 42 34 67
DIGOXIN 69 55 34 39
TRIAMCINOLONE ACETONIDE 68 19 36 105
COMBIVENT 67 26 37 107
CYCLOBENZAPRINE HCL 65 11 R 38 86
DONEPEZIL HCL 64 64 39 24
FLUTICASONE PROPIONATE 63 13 40 40
JANUVIA 61 27 41 81
POLYETHYLENE GLYCOL 3350 60 17 42 41
LEVOTHYROXINE SODIUM 59 23 43 2
RANITIDINE HCL 57 28 44 42
AMOXICILLIN 53 21 45 171
SERTRALINE HCL 52 33 46 23
SPIRONOLACTONE 51 19 47 44
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.